Cargando…

Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression Marker

BACKGROUND: Development of reliable and accurate imaging biomarkers of dopaminergic cell neurodegeneration is necessary to facilitate therapeutic drug trials in Parkinson's disease (PD). Neuromelanin‐sensitive MRI techniques have been effective in detecting neurodegeneration in the substantia n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaurav, Rahul, Yahia‐Cherif, Lydia, Pyatigorskaya, Nadya, Mangone, Graziella, Biondetti, Emma, Valabrègue, Romain, Ewenczyk, Claire, Hutchison, R. Matthew, Cedarbaum, Jesse M., Corvol, Jean‐Christophe, Vidailhet, Marie, Lehéricy, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359265/ https://www.ncbi.nlm.nih.gov/pubmed/33751655 http://dx.doi.org/10.1002/mds.28531

Ejemplares similares

Deep Learning‐Based Neuromelanin MRI Changes of Isolated REM Sleep Behavior Disorder
por: Gaurav, Rahul, et al.
Publicado: (2022)

The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease
por: Biondetti, Emma, et al.
Publicado: (2021)

NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural network
por: Gaurav, Rahul, et al.
Publicado: (2022)

Iron Imaging as a Diagnostic Tool for Parkinson's Disease: A Systematic Review and Meta-Analysis
por: Pyatigorskaya, Nadya, et al.
Publicado: (2020)

Multimodal magnetic resonance imaging investigation of basal forebrain damage and cognitive deficits in Parkinson's disease
por: Gargouri, Fatma, et al.
Publicado: (2018)

Relationship between Substantia Nigra Neuromelanin Imaging and Dual Alpha-Synuclein Labeling of Labial Minor in Salivary Glands in Isolated Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease
por: Mangone, Graziella, et al.
Publicado: (2022)

X-Vectors: New Quantitative Biomarkers for Early Parkinson's Disease Detection From Speech
por: Jeancolas, Laetitia, et al.
Publicado: (2021)

The Role of Magnetic Resonance Imaging for the Diagnosis of Atypical Parkinsonism
por: Chougar, Lydia, et al.
Publicado: (2020)

The Myelin‐Weighted Connectome in Parkinson's Disease
por: Boshkovski, Tommy, et al.
Publicado: (2021)

Neuromelanin and T(2)*-MRI for the assessment of genetically at-risk, prodromal, and symptomatic Parkinson’s disease
por: Ben Bashat, Dafna, et al.
Publicado: (2022)

Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
por: Vila, Miquel
Publicado: (2019)

Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role
por: Zucca, Fabio A., et al.
Publicado: (2022)

Brain dysfunction in gait disorders of Caribbean atypical Parkinsonism and progressive supranuclear palsy patients: A comparative study
por: Welter, Marie-Laure, et al.
Publicado: (2023)

The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson’s disease
por: García-Lorenzo, Daniel, et al.
Publicado: (2013)

The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson’s disease
por: Nagatsu, Toshiharu, et al.
Publicado: (2023)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase
por: Nagatsu, Toshiharu, et al.
Publicado: (2022)

Application of Neuromelanin MR Imaging in Parkinson Disease
por: He, Naying, et al.
Publicado: (2022)

Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022)

Neuromelanin‐Sensitive Magnetic Resonance Imaging Using DANTE Pulse
por: Oshima, Sonoko, et al.
Publicado: (2020)

Alterations of the nigrostriatal pathway in a 6-OHDA rat model of Parkinson’s disease evaluated with multimodal MRI
por: Perlbarg, Vincent, et al.
Publicado: (2018)

An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson’s disease using neuromelanin-sensitive MRI
por: Liu, Qiang, et al.
Publicado: (2023)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Multivariate prediction of functional outcome using lesion topography characterized by acute diffusion tensor imaging
por: Moulton, Eric, et al.
Publicado: (2019)

Neuromelanin‐MRI to Quantify and Track Nigral Depigmentation in Parkinson's Disease: A Multicenter Longitudinal Study Using Template‐Based Standardized Analysis
por: Xing, Yue, et al.
Publicado: (2022)

Are Frontal Cognitive and Atrophy Patterns Different in PSP and bvFTD? A Comparative Neuropsychological and VBM Study
por: Lagarde, Julien, et al.
Publicado: (2013)

The protective and toxic role of neuromelanins in brain aging and Parkinson’s disease
por: Zecca, Luigi, et al.
Publicado: (2015)

Corrigendum to: Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson’s disease
Publicado: (2020)

Altered structural connectivity of cortico-striato-pallido-thalamic networks in Gilles de la Tourette syndrome
por: Worbe, Yulia, et al.
Publicado: (2015)

The Influence of Preprocessing Steps on Graph Theory Measures Derived from Resting State fMRI
por: Gargouri, Fatma, et al.
Publicado: (2018)

Hyperglycaemia, Insulin Therapy and Critical Penumbral Regions for Prognosis in Acute Stroke: Further Insights from the INSULINFARCT Trial
por: Rosso, Charlotte, et al.
Publicado: (2015)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson’s disease
por: Gonzalez-Sepulveda, Marta, et al.
Publicado: (2023)

Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s Disease
por: Pizarro-Galleguillos, Benjamin Matis, et al.
Publicado: (2022)

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease
por: Riederer, Peter, et al.
Publicado: (2023)

Fronto-striato-thalamic circuit connectivity and neuromelanin in schizophrenia: an fMRI and neuromelanin-MRI study
por: Choi, Sunah, et al.
Publicado: (2023)

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
por: Carballo-Carbajal, Iria, et al.
Publicado: (2019)

Predictive markers for Parkinson's disease using deep neural nets on neuromelanin sensitive MRI
por: Shinde, Sumeet, et al.
Publicado: (2019)

Melanin and Neuromelanin Fluorescence Studies Focusing on Parkinson’s Disease and Its Inherent Risk for Melanoma
por: Leupold, Dieter, et al.
Publicado: (2019)

Substantia nigra neuromelanin magnetic resonance imaging in patients with different subtypes of Parkinson disease
por: Wang, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_81g3gukhkm59664a5ndbhpkkad